Recombinant ACLY antibody (C-Term)
Quick Overview for Recombinant ACLY antibody (C-Term) (ABIN6942175)
Target
See all ACLY AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Purpose
- ACLY Recombinant Antibody
-
Cross-Reactivity
- Human, Mouse, Rat
-
Purification
- Purified by Protein A.
-
Immunogen
- C-terminus Human ATP-citrate synthase
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB(WB(1:500-2000)), FCM(FCM(1:50-100)), IHC-P(IHC-P(1:50-200)), IHC-F(IHC-F(1:50-200)), IF(IHC-P)(IF(IHC-P)(1:20-100)), IF(ICC)(IF(ICC)(1:50-200))
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- 0.01M TBS ( pH 7.4), 1 % BSA, 0.02 % Proclin 300, and 50 % Glycerol
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- ACLY (ATP Citrate Lyase (ACLY))
-
Alternative Name
- ATP citRate lyase
-
Background
-
Synonyms: ATP-citrate synthase, ATP-citrate (pro-S-)-lyase, citrate cleavage enzyme, ACL, ACLY
Background: ATP-citrate synthase is the primary enzyme responsible for the synthesis of cytosolic acetyl-CoA in many tissues. Has a central role in de novo lipid synthesis. In nervous tissue it may be involved in the biosynthesis of acetylcholine.
-
Gene ID
- 47
-
UniProt
- P53396
-
Pathways
- Warburg Effect
Target
-